Pulsecare Medical’s nsPFA clinical trial receives satisfactory short-term follow-up results

SHENZHEN, China, Oct. 30, 2023 /PRNewswire/ — Pulsecare Medical, an innovative minimally invasive and non-invasive therapeutic technology company, announced today that its nanosecond pulsed field ablation (nsPFA) system for cardiac electrophysiology, the world’s first third-generation…